271 related articles for article (PubMed ID: 29678631)
1. Platelet-to-lymphocyte ratio in advanced Cancer: Review and meta-analysis.
Li B; Zhou P; Liu Y; Wei H; Yang X; Chen T; Xiao J
Clin Chim Acta; 2018 Aug; 483():48-56. PubMed ID: 29678631
[TBL] [Abstract][Full Text] [Related]
2. Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2018 May; 480():166-172. PubMed ID: 29462592
[TBL] [Abstract][Full Text] [Related]
3. Prognostic role of platelet to lymphocyte ratio in non-small cell lung cancers: A meta-analysis including 3,720 patients.
Zhao QT; Yuan Z; Zhang H; Zhang XP; Wang HE; Wang ZK; Duan GC
Int J Cancer; 2016 Jul; 139(1):164-70. PubMed ID: 26915723
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.
Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W
Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of platelet-to-lymphocyte ratio in patients with ovarian cancer: A meta-analysis.
Tian C; Song W; Tian X; Sun Y
Eur J Clin Invest; 2018 May; 48(5):e12917. PubMed ID: 29469190
[TBL] [Abstract][Full Text] [Related]
6. Prognostic role of neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in prostate cancer: A meta-analysis of results from multivariate analysis.
Guo J; Fang J; Huang X; Liu Y; Yuan Y; Zhang X; Zou C; Xiao K; Wang J
Int J Surg; 2018 Dec; 60():216-223. PubMed ID: 30468905
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the prognostic role of platelet-lymphocyte ratio in cancer patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis.
Xu H; He A; Liu A; Tong W; Cao D
Int Immunopharmacol; 2019 Dec; 77():105957. PubMed ID: 31677498
[TBL] [Abstract][Full Text] [Related]
8. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
9. The prognostic role of pretreatment platelet-to-lymphocyte ratio as predictors in patients with colorectal cancer: a meta-analysis.
Min GT; Wang YH; Yao N; Zhao JM; Wang J; Wang HP; Chen W; Deng SJ; Li YM
Biomark Med; 2017 Jan; 11(1):87-97. PubMed ID: 27917650
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of the platelet to lymphocyte ratio (PLR) in the clinical outcomes of patients with advanced lung cancer receiving immunotherapy: A systematic review and meta-analysis.
Zhou K; Cao J; Lin H; Liang L; Shen Z; Wang L; Peng Z; Mei J
Front Oncol; 2022; 12():962173. PubMed ID: 36059629
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as biomarkers to prognosticate survival in advanced gastric cancer patients in the era of immunotherapy: a systematic review and meta-analysis.
Matsas S; Aguiar PN; Del Giglio A
J Gastrointest Oncol; 2024 Feb; 15(1):33-51. PubMed ID: 38482212
[TBL] [Abstract][Full Text] [Related]
12. Are pretreatment neutrophil-lymphocyte ratio and platelet-lymphocyte ratio useful in predicting the outcomes of patients with small-cell lung cancer?
Deng M; Ma X; Liang X; Zhu C; Wang M
Oncotarget; 2017 Jun; 8(23):37200-37207. PubMed ID: 28380461
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
[TBL] [Abstract][Full Text] [Related]
14. Prognostic role of pretreatment platelet to lymphocyte ratio in urologic cancer.
Wang J; Liu Y; Zhang N; Li X; Xin P; Bi J; Kong C
Oncotarget; 2017 Sep; 8(41):70874-70882. PubMed ID: 29050328
[TBL] [Abstract][Full Text] [Related]
15. An Elevated Platelet-to-Lymphocyte Ratio Predicts Poor Prognosis and Clinicopathological Characteristics in Patients with Colorectal Cancer: A Meta-Analysis.
Huang XZ; Chen WJ; Zhang X; Wu CC; Zhang CY; Sun SS; Wu J
Dis Markers; 2017; 2017():1053125. PubMed ID: 28539688
[No Abstract] [Full Text] [Related]
16. [Meta-analysis of Platelet Lymphocyte Ratio as A Prognostic Factor for
Non-small Cell Lung Cancer].
Chen H; Xue H; Liu W; Wu F; Wang Y; Gao H
Zhongguo Fei Ai Za Zhi; 2019 May; 22(5):289-298. PubMed ID: 31109438
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of platelet to lymphocyte ratio in solid tumors: a systematic review and meta-analysis.
Templeton AJ; Ace O; McNamara MG; Al-Mubarak M; Vera-Badillo FE; Hermanns T; Seruga B; Ocaña A; Tannock IF; Amir E
Cancer Epidemiol Biomarkers Prev; 2014 Jul; 23(7):1204-12. PubMed ID: 24793958
[TBL] [Abstract][Full Text] [Related]
18. Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta-analysis.
Tan Q; Liu S; Liang C; Han X; Shi Y
Thorac Cancer; 2018 Oct; 9(10):1220-1230. PubMed ID: 30151899
[TBL] [Abstract][Full Text] [Related]
19. Clinicopathological and prognostic significance of platelet to lymphocyte ratio in patients with gastric cancer.
Gu X; Gao XS; Cui M; Xie M; Peng C; Bai Y; Guo W; Han L; Gu X; Xiong W
Oncotarget; 2016 Aug; 7(31):49878-49887. PubMed ID: 27409665
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of platelet to lymphocyte ratio in non-small cell lung cancer: evidence from 3,430 patients.
Gu X; Sun S; Gao XS; Xiong W; Qin S; Qi X; Ma M; Li X; Zhou D; Wang W; Yu H
Sci Rep; 2016 Mar; 6():23893. PubMed ID: 27025911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]